
Ortho Development commenced full commercial launch of the Trivicta Hip Stem, a cementless triple-taper femoral component for primary total hip arthroplasty. Following a controlled market introduction, the system is now available to surgeons and health systems through Ortho Development’s authorized U.S. distribution network.
The Trivicta Hip System received FDA 510(k) marketing clearance in early 2024.
Trivicta strengthens Ortho Development’s hip portfolio with a refined femoral stem designed to support stability, versatility and efficiency. The system incorporates a full 35 μm hydroxyapatite coating over sintered titanium beads to support early osteointegration, along with standard and extended offset options designed to provide direct lateralization without affecting leg length. Progressive neck lengths and a refined distal geometry further support anatomical versatility across a range of femoral morphologies.
A hybrid broach system with integrated anterior and posterior compaction teeth is designed to preserve bone while supporting accurate implant seating. Modular instrumentation and incremental stem sizing are intended to streamline preparation and reduce variability in placement across surgical approaches.
Source: Ortho Development Corporation
Ortho Development commenced full commercial launch of the Trivicta Hip Stem, a cementless triple-taper femoral component for primary total hip arthroplasty. Following a controlled market introduction, the system is now available to surgeons and health systems through Ortho Development's authorized U.S. distribution network.
The Trivicta Hip...
Ortho Development commenced full commercial launch of the Trivicta Hip Stem, a cementless triple-taper femoral component for primary total hip arthroplasty. Following a controlled market introduction, the system is now available to surgeons and health systems through Ortho Development’s authorized U.S. distribution network.
The Trivicta Hip System received FDA 510(k) marketing clearance in early 2024.
Trivicta strengthens Ortho Development’s hip portfolio with a refined femoral stem designed to support stability, versatility and efficiency. The system incorporates a full 35 μm hydroxyapatite coating over sintered titanium beads to support early osteointegration, along with standard and extended offset options designed to provide direct lateralization without affecting leg length. Progressive neck lengths and a refined distal geometry further support anatomical versatility across a range of femoral morphologies.
A hybrid broach system with integrated anterior and posterior compaction teeth is designed to preserve bone while supporting accurate implant seating. Modular instrumentation and incremental stem sizing are intended to streamline preparation and reduce variability in placement across surgical approaches.
Source: Ortho Development Corporation
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





